Hofman J, Michalska I, Rutkowski R, Chyrek-Borowska S
Department of Allergology, Medical School in Białystok, Poland.
Agents Actions. 1988 Apr;23(3-4):370-2. doi: 10.1007/BF02142590.
The aim of the present study was to evaluate lung function and bronchial reactivity during therapy with the H2-blockers, cimetidine and ranitidine, in order to determine the role of H2-receptors in the bronchial response of asthmatic patients. Bronchial reactivity was evaluated by the histamine provocation test before, and 3 or 6 days after administration of cimetidine (800 mg per day) or ranitidine (300 mg per day). It was shown that after 6 days treatment, an increase in bronchial reactivity occurred in 85% of the patients treated with cimetidine and in 64% of the patients treated with ranitidine. These results seem to confirm the presence of H2 receptors in the bronchial tree of asthmatic patients. Blockade of these receptors causes an increase in bronchial reactivity and potential exacerbation of the asthmatic symptoms.
本研究的目的是评估H2受体阻滞剂西咪替丁和雷尼替丁治疗期间的肺功能和支气管反应性,以确定H2受体在哮喘患者支气管反应中的作用。在给予西咪替丁(每日800毫克)或雷尼替丁(每日300毫克)之前以及给药后3天或6天,通过组胺激发试验评估支气管反应性。结果显示,治疗6天后,接受西咪替丁治疗的患者中有85%出现支气管反应性增加,接受雷尼替丁治疗的患者中有64%出现支气管反应性增加。这些结果似乎证实了哮喘患者支气管树中存在H2受体。阻断这些受体会导致支气管反应性增加,并可能加重哮喘症状。